Role of the complement in experimental sepsis

Journal of Leukocyte Biology

Volumn 83, Issue 3, 2008, Pages 467-470

  Ward, Peter A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

C5a; C5aR; Inflammation; Mediators

Indexed keywords

COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; CHEMOKINE RECEPTOR; COMPLEMENT; GPR77 PROTEIN, HUMAN;

CONFERENCE PAPER; HUMAN; IMMUNE RESPONSE; LEUKOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE; UPREGULATION; ANIMAL; ARTICLE; BLOOD; DISEASE MODEL; PHYSIOLOGY;

MUS; RATTUS; RODENTIA;

ANIMALS; COMPLEMENT SYSTEM PROTEINS; DISEASE MODELS, ANIMAL; HUMANS; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, CHEMOKINE; SEPSIS;

EID: 43349093340     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0607376     Document Type: Conference Paper

References (26)

1. Riedemann, N. C., Guo, R. F., Ward, P. A. (2003) Novel strategies for the treatment of sepsis. Nat. Med. 9, 517-524.
2. Rabiet, M. J., Huet, E., Boulay, F. (2007) The N-formyl peptide receptors and the anaphylatoxin C5a receptors: an overview. Biochimie 89, 1089-1106-.
3. Guo, R. F., Ward, P. A. (2005) Role of C5a in inflammatory responses. Annu. Rev. Immunol. 23, 821-852.
4. Huber-Lang, M., Younkin, E. M., Sarma, J. V., Riedemann, N., McGuire, S. R., Lu, K. T., Kunkel, R., Younger, J. G., Zetoune, F. S., Ward, P. A. (2002) Generation of C5a by phagocytic cells. Am. J. Pathol. 161, 1849-1859.
5. Huber-Lang, M., Sarma, J. V., Zetoune, F. S., Rittirsch, D., Neff, T. A., McGuire, S. R., Lambris, J. D., Warner, R. L., Flierl, M. A., Hoesel, L. M., et al. (2006) Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 12, 682-687.
6. Riedemann, N. C., Guo, R. F., Neff, T. A., Laudes, I. J., Keller, K. A., Sarma, J. V., Markiewski, M. M., Mastellos, D., Strey, C. W., Pierson, C. L., Lambris, J. D., Zetoune, F. S., Ward, P. A. (2002) Increased C5a receptor expression in sepsis. J. Clin. Invest. 110, 101-108.
7. Riedemann, N. C., Guo, R. F., Laudes, I. J., Keller, K., Sarma, V. J., Padgaonkar, V., Ward, P. A. (2002) C5a receptor and thymocyte apoptosis in sepsis. FASEB J. 16, 887-888.
8. Niederbichler, A. D., Hoesel, L. M., Westfall, M. V., Gao, H., Ipaktchi, K. R., Sun, L., Zetoune, F. S., Su, G. L., Arbabi, S., Sarma, J. V., et al. (2005) An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction. J. Exp. Med. 203, 53-61.
9. Riedemann, N. C., Guo, R. F., Laudes, I. J., Keller, K., Sarma, V. J., Padgaonkar, V., Ward, P. A. (2002) C5a receptor and thymocyte apoptosis in sepsis. FASEB J. 16, 887-888.
10. Hotchkiss, R. S., Nicholson, D. W. (2006) Apoptosis and caspases regulate death and inflammation in sepsis. Nat. Rev. Immunol. 6, 813-822.
11. Riedemann, N. C., Neff, T. A., Guo, R. F., Bernacki, K. D., Laudes, I. J., Sarma, J. V., Lambris, J. D., Ward, P. A. (2003) Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J. Immunol. 170, 503-507.
12. Guo, R. F., Riedemann, N. C., Bernacki, K. D., Sarma, J. V., Laudes, I. J., Reuben, J. S., Younkin, E. M., Neff, T. A., Paulauskis, J. D., Zetoune, F. S., Ward, P. A. (2003) Neutrophil C5a receptor and the outcome in a rat model of sepsis. FASEB J. 17, 1889-1891.
13. Cain, S. A., Monk, P. N. (2002) The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74). J. Biol. Chem. 277, 7165-7169.
14. Okinaga, S., Slattery, D., Humbles, A., Zsengeller, Z., Morteau, O., Kinrade, M. B., Brodbeck, R. M., Krause, J. E., Choe, H. R., Gerard, N. P., Gerard, C. (2003) C5L2, a nonsignaling C5A binding protein. Biochemistry 42, 9406-9415.
15. Johswich, K., Martin, M., Thalmann, J., Rheinheimer, C., Monk, P. N., Klos, A. (2006) Ligand specificity of the anaphylatoxin C5L2 receptor and its regulation on myeloid and epithelial cell lines. J. Biol. Chem. 281, 39088-39095.
16. Kalant, D., MacLaren, R., Cui, W., Samanta, R., Monk, P. N., Laporte, S. A., Cianflone, K. (2005) C5L2 is a functional receptor for acylation-stimulating protein. J. Biol. Chem. 280, 23936-23944.
17. Kalant, D., Cain, S. A., Maslowska, M., Sniderman, A. D., Cianflone, K., Monk, P. N. (2003) The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein. J. Biol. Chem. 278, 11123-11129.
18. Chen, N. J., Mirtsos, C., Suh, D., Lu, Y. C., Lin, W. J., McKerlie, C., Lee, T., Baribault, H., Tian, H., Yeh, W. C. (2007) C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a. Nature 446, 203-207.
19. Gao, H., Neff, T. A., Guo, R. F., Speyer, C. L., Sarma, J. V., Tomlins, S., Man, Y., Riedemann, N. C., Hoesel, L. M., Younkin, E. M., Zetoune, F. S., Ward, P. A. (2005) Evidence for a functional role of the second C5a receptor, C5L2. FASEB J. 19, 1003-1005.
20. Gerard, N. P., Lu, B., Liu, P., Craig, S., Fujiwara, Y., Okinaga, S., Gerard, C. (2005) An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2. J. Biol. Chem. 280, 39677-39680.
21. Czermak, B. J., Sarma, V., Pierson, C. L., Warner, R. L., Huber-Lang, M., Bless, N. M., Schmal, H., Friedl, H. P., Ward, P. A. (1999) Protective effects of C5a blockade in sepsis. Nat. Med. 5, 788-792.
22. Huber-Lang, M. S., Sarma, J. V., McGuire, S. R., Lu, K. T., Guo, R. F., Padgaonkar, V. A., Younkin, E. M., Laudes, I. J., Riedemann, N. C., Younger, J. G., Ward, P. A. (2001) Protective effects of anti-C5a peptide antibodies in experimental sepsis. FASEB J. 15, 568-570.
23. Huber-Lang, M. S., Younkin, E. M., Sarma, J. V., McGuire, S. R., Lu, K. T., Guo, R. F., Padgaonkar, V. A., Curnutte, J. T., Erickson, R., Ward, P. A. (2002) Complement-induced impairment of innate immunity during sepsis. J. Immunol. 169, 3223-3231.
24. Laudes, I. J., Chu, J. C., Sikranth, S., Huber-Lang, M., Guo, R. F., Riedemann, N., Sarma, J. V., Schmaier, A. H., Ward, P. A. (2002) Anti-C5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis. Am. J. Pathol. 160, 1867-1875.
25. Huber-Lang, M. S., Riedemann, N. C., Sarma, J. V., Younkin, E. M., McGuire, S. R., Laudes, I. J., Lu, K. T., Guo, R., Neff, T. A., Padgaonkar, V. A., et al. (2002) Protection of innate immunity by C5aR antagonist in septic mice. FASEB J. 16, 1567-1574.
26. Huber-Lang, M., Sarma, J. V., Rittirsch, D., Schreiber, H., Weiss, M., Flierl, M., Younkin, E., Schneider, M., Suger-Wiedeck, H., Gebhard, F., et al. (2005) Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans. J. Immunol. 174, 1104-1110.